This section contains the latest information and guidance for health professionals, in response to the swine flu pandemic.
Letter from Sir Liam Donaldson, Chief Medical Officer. With levels of influenza caused by the H1N1 (2009) pandemic virus in the community currently low, this letter provides an update on the next developments in the response to the pandemic.
Letter from Ian Dalton, National Director of NHS Flu Resilience on the latest phase of our response to the H1N1 virus (swine flu).
This document is an updated version of Pandemic flu: A summary of guidance for infection control in health care settings issued in September 2007.1 It is specific to the current pandemic influenza virus, pandemic (H1N1), and thus represents current guidance.
The purpose of this document is to set out concise summary guidance on infection control for the ambulance services and it is intended for use during the pandemic. The guidance in this document is equally applicable to lay responders, who should adopt the same infection control and hygiene measures.
An FFP3 respirator should be worn by frontline staff when carrying out aerosol-generating procedures. It is a legal requirement that anybody who might be required to wear an FFP3 respirator be fit tested in order to check that an adequate seal can be achieved with each specific model. It is also important that the user carries out a fit check each time an FFP3 respirator is worn.
These downloadable posters and leaflet are designed to complement the FFP3 fit test training sessions being rolled out by trusts. They provide visual and practical information on:
The Central Alerting System brings together CMO’s Public Health Link (PHL) and the Safety Alert Broadcast System (SABS). It enables alerts and urgent patient safety specific guidance to be accessed at any time.
The MHRA is closely monitoring the safety of products (such as Tamiflu and Relenza) used for the treatment and prevention of swine flu during the pandemic.